S. Yarman Et Al. , "Optimal effective doses of cabergoline and bromocriptine and valvular leasions in men with prolactinomas," NEUROENDOCRINOLOGY LETTERS , vol.33, no.3, pp.340-346, 2012
Yarman, S. Et Al. 2012. Optimal effective doses of cabergoline and bromocriptine and valvular leasions in men with prolactinomas. NEUROENDOCRINOLOGY LETTERS , vol.33, no.3 , 340-346.
Yarman, S., Kurtulmus, N., & Bilge, A., (2012). Optimal effective doses of cabergoline and bromocriptine and valvular leasions in men with prolactinomas. NEUROENDOCRINOLOGY LETTERS , vol.33, no.3, 340-346.
Yarman, Emine, Neslihan Kurtulmus, And Ahmet Bilge. "Optimal effective doses of cabergoline and bromocriptine and valvular leasions in men with prolactinomas," NEUROENDOCRINOLOGY LETTERS , vol.33, no.3, 340-346, 2012
Yarman, Emine S. Et Al. "Optimal effective doses of cabergoline and bromocriptine and valvular leasions in men with prolactinomas." NEUROENDOCRINOLOGY LETTERS , vol.33, no.3, pp.340-346, 2012
Yarman, S. Kurtulmus, N. And Bilge, A. (2012) . "Optimal effective doses of cabergoline and bromocriptine and valvular leasions in men with prolactinomas." NEUROENDOCRINOLOGY LETTERS , vol.33, no.3, pp.340-346.
@article{article, author={Emine Sema YARMAN Et Al. }, title={Optimal effective doses of cabergoline and bromocriptine and valvular leasions in men with prolactinomas}, journal={NEUROENDOCRINOLOGY LETTERS}, year=2012, pages={340-346} }